Insights provides context and perspective about key pharmacy trends and issues

A Thriving Pipeline Expected to Continue Expanding Treatment Options
Drug Pipeline
Our periodic gene therapy report helps payor better understand the potential for these innovative treatments to transform patient care and outcomes More
Briefing
Understanding Health Disparities in Diabetes
Care Management
This white paper presents perspective from Sree Chaguturu, MD, Chief Medical Officer, CVS Caremark about how social determinants affect disparities in diabetes including disease burden,... More
White Paper
Addressing Diabetes Care Challenges
Care Management
CVS Health addresses diabetes care challenges with its Transform Diabetes Care that offers a customized, clinical, and convenient approach. More
Briefing
Ensuring Better Kidney Care
Care Management
CVS Health ensures better kidney care using advanced algorithms to drive patient identification and care management. More
Briefing
Identifying Gaps in Care for Rheumatoid Arthritis
Cost Management
CVS Health research highlights gaps in diagnosis and treatment of rheumatoid arthritis to help address cost, care, and patient outcomes. More
Briefing
ACA Returns to Court
Public Policy
The California vs. Texas case before the U.S. Supreme Court could help determine the future of the Affordable Care Act (ACA), and could lead to one of several different results. More
Commentary
IBD Treatment Options on the Rise
Specialty
Our proven strategies including step therapy, Specialty Guideline Management, and cross-benefit management can help clients better manage costs for the growing number of IBD treatments. More
Feature
Speciality Pharmacy Pipeline Drugs to Watch | Q4 2020 - Q1 2021
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q4 2020 - Q1 2021 More
Specialty Report
Public Policy
If ERISA pre-emption is not upheld for self-funded ERISA plans using PBMs to administer prescription drug benefits, we believe the implications may create unsustainable complexity and cost... More
Commentary
Care Management
While the focus is on a possible vaccine for COVID-19, letting rates of immunizations slip for preventable diseases for which vaccines are available can have enormous economically and... More
White Paper